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Figure 2. Grading of breast density on a mammogram.
we have known for some time that a dense breast on mammography presents diagnostic problems in the detection of breast cancer. It has also been suggested that 
women with dense breasts are at a higher risk for developing 
breast cancer. 
The aim of this article is to update the reader on current 
thoughts and data on the above issues and discusses the 
use of supplemental imaging in women with dense breasts, 
including digital breast tomosynthesis (DBT), whole-breast 
ultrasonography (WBUS), automated whole-breast US 
(ABUS), and gadolinium-enhanced breast magnetic resonance 
(MR) imaging. 
Breast density refers to the visual characteristics of the 
breast on mammograms. Breasts containing a high proportion 
of parenchymal elements and ducts compared to background 
fatty tissue are considered dense, while those containing a 
higher proportion fatty tissue are considered non-dense or 
fatty in composition. In layman’s terms, a dense breast has 
more “white” elements that may be patchy or confluent (Fig 
1a), while a fatty or non-dense breast contains more “dark” 
elements (Fig 1b) on a mammogram. 
Breast density does not correlate with firmness noted on 
clinical palpation. A firm breast may have a predominantly fatty 
composition, while a soft breast may have a dense composition 
on mammography. 
Breast density has been classified into four groups: fatty 
breasts, scattered fibro-glandular elements, heterogeneously 
dense breasts and very (or homogeneously) dense breasts 
(Fig 2). There is significant variation in classification between 
different observers and even between repeat reviews by the same 
observer, particularly towards the middle of the scale, due to its 
non-quantitative nature. There have been attempts to quantify 
breast density on digital mammograms through software 
analysis with very limited success.
Data from the Breast Cancer Surveillance Consortium 
(BCSC) collected from registries around the United States 
show that on 934,098 normal screening mammograms 
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obtained from 1994 to 2008, the distribution according to 
tissue density was as follows: 9.0% of breasts were fatty breasts, 
44.1% were breasts with scattered areas of fibro glandular 
densities 38.3% were heterogeneously dense breasts, and 8.6% 
were extremely (or “homogeneously”) dense breasts. In clinical 
practice, fatty breasts and those with scattered fibro glandular 
elements are referred to as non-dense breasts, while those 
that are heterogeneously or extremely dense are referred to as 
dense breasts. 
Importantly, breast density diminishes with increasing 
patient age and body mass index. A decrease in blood oestrogen 
and progesterone levels as seen most notably at menopause, will 
Figure 1. Mammograms showing a heterogeneously dense breast (a) compared 
to a fatty breast (b). 
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higher breast density May 
obscure a breast cancer during 
MaMMographic evaluation and 
result in later diagnosis
result in a decrease in glandular and ductal components and a 
relative increase in fatty components in the breast. Weight-loss 
or gain will influence the fat content in the breast and will alter 
breast density (Fig 3). 
Higher breast density may obscure a breast cancer during 
mammographic evaluation and result in later diagnosis when 
the cancer is more advanced. This observation has led to the 
introduction of legislative changes in several states in the USA 
that obliges the radiologist to notify the patient regarding her 
breast density and the possible need for supplemental imaging. 
There is considerable evidence that breast cancers can be 
obscured by dense breast tissue. Past studies have used the 
concept of interval cancers to distinguish those cancers that 
appeared on mammograms obtained within 1 year of the prior 
mammograms. Non-interval cancers were those detected 
after a period greater than 12 months from the previous 
mammograms. It was found that in women with dense breasts, 
the proportion of interval cancers was significantly higher 
than in those with non-dense breasts. The incidence of non-
interval cancers was higher in women with non-dense breast 
that in those with dense breasts. This lead to the conclusion that 
very early signs of breast cancer may have been obscured by 
abundant parenchymal elements in dense breasts on the initial 
mammograms. 
Other supporting evidence for the obscuring effect caused by 
dense parenchymal elements has been obtained through the use 
of supplemental investigations such as breast ultrasound (US), 
digital breast tomosynthesis (DBT) and breast MRI, which help 
detect cancers that are not visible in dense breasts. Numerous 
studies have evaluated the use of supplemental imaging to 
improve breast cancer detection, however significant differences 
in study design and patient selection criteria between these 
studies make it difficult to reach concrete conclusions. 
A most significant improvement in the ability to evaluate 
the dense breast was seen with the introduction of Digital 
Mammography. The image quality provided by digital 
mammograms significantly improved visualisation of the dense 
breast compared to earlier film/screen mammograms. There 
are two types of digital mammograms: Computed Radiography 
(CR) Mammograms and Full Field Digital Mammograms (also 
known as DR Mammograms). DR Mammograms have a much 
better image quality than CR Mammograms (Fig 4). FFDM is 
the gold standard for breast cancer screening today.
A standard strategy used by most radiologists when faced 
with a mammogram showing dense breasts is to proceed to a 
breast ultrasound (or WBUS) to obtain a second view of those 
difficult-to-analyse areas on the mammogram. Breast ultrasound 
does not rely on tissue density to create an image, it relies on 
tissue and cell interfaces that act as acoustic reflectors. What is 
seen a dense on mammography is usually well penetrated by the 
ultrasound beam. Mammographically difficult areas in the breast 
are usually cleared with a breast ultrasound often performed in 
the same sitting (Fig 5) providing an efficient and effective mode 
of patient management. 
Figure 3. Mammograms of the same patient taken 2 years apart, (a) before and 
(b) after considerable weight loss.
a b
Figure 4. DR (a) vs CR (b) Mammograms: The same lesion (arrow) is more 
clearly depicted on the DR mammogram than on the CR mammogram. 
a b
Figure 5. Suspected lesion (arrow) on mammogram (a) was clearly confirmed on 
breast ultrasound (b). 
a b
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Breast ultrasound is widely available and inexpensive, but 
it is strongly both operator and technology dependent. The 
abundance of older ultrasound machines in many hospitals 
and radiology practices and the lack of trained expertise would 
significantly reduce its value for breast cancer detection. The 
approval of ABUS but the FDA (Food and Drug Administration, 
USA) in 2011, may take a step towards improving the situation. 
ABUS takes a mechanically-controlled scan through the whole 
breast and records a 3D image for review by the radiologist. The 
inherent advantage of free-hand breast ultrasound is that the 
examiner is able to rotate the probe to select the best plane of 
lesion visibility. This is not possible with ABUS. ABUS has not 
been approved for breast cancer screening.  
DBT is a new technology based on DR Mammography, 
which obtains a series of images at different levels through the 
breast similar to the consecutive slices obtained with Computed 
Tomography (CT). Sometimes referred to as 3D mammography, it 
is not a 3D imaging method as the thickness of the slices obtained 
is too large to allow 3D reconstructions. DBT appears to be of 
value in the dense breast as it reduces lesion superimposition by 
dense parenchymal structure (Fig 6). However, DBT is used as an 
adjunct to standard DR mammograms with the consequence that 
there is a doubling of radiation exposure to the patient if DBT is 
performed in just one plane. DBT is therefore not recommended 
in this format as a screening method for breast cancer. It can 
be used to evaluate patients with abnormal mammograms or 
those with significant clinical suspicion. The possibility to create 
synthesised DR mammograms from DBT data would reduce the 
radiation exposure by avoiding initial DR Mammography and 
may in future lead DBT becoming a primary screening tool. 
MR Imaging of the breast is the most sensitive test available 
for detecting breast cancer. It will depict more cancers that DR 
Mammography or Breast Ultrasound, but it also has a higher 
false positive rate, which would result in unnecessary breast 
biopsies. There are clear guidelines that recommend the use of 
breast MR imaging for screening women with a high risk for 
breast cancer. Whether it should also be used for intermediate 
or low risk women is as yet undecided. Breast MR imaging 
depends on morphological features and contrast enhancement 
characteristics to detect cancerous lesions in the breast (Fig 7). 
Long examination times, limited scanner availability, high cost 
and the need for intravenous injection of contrast material limit 
the use of MR imaging for breast cancer screening.
A further question relating to the dense breast is whether 
breast density in itself makes the patient more prone to breast 
cancer. This is a subject under constant debate. The higher volume 
of glandular and ductal elements in dense breasts, which are 
the tissues that give rise to breast cancer, may raise the patient’s 
risk. There is some statistical evidence that breast density may 
influence a patient’s risk to develop breast cancer, however other 
risk factors such as positive breast cancer gene testing, family and 
personal history and obesity and smoking play a greater role. 
The dense breast poses a very frequent problem encountered 
in the breast cancer screening with mammography. The use 
of supplemental imaging, mainly breast ultrasound and MR 
imaging, significantly improves the accuracy of diagnostic 
assessment in the mammographically dense breast. Finally, 
correlation of clinical with imaging data is of great importance 
as clinical data may provide helpful guidance in those difficult 
areas in the dense breast. 
Figure 6. Subtle lesion (arrow) seen on DR mammogram (a) better seen on 
supplemental DBT (b).
Figure 7. Two cases of cancer (a and b) obscured in dense breasts that were 
visible (arrows) on MR imaging. 
a b b
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